CORD-19:e847d433e7424152a9846673209cb73027415ecd / 98883-99057 JSONTXT

{"target":"https://pubannotation.org/docs/sourcedb/CORD-19/sourceid/e847d433e7424152a9846673209cb73027415ecd","sourcedb":"CORD-19","sourceid":"e847d433e7424152a9846673209cb73027415ecd","text":"Tigecycline (TIG), a new glycylcycline, promises enhanced activity against many multi-drug resistant phenotypes of community and nosocomial pathogens causing serious disease.","tracks":[{"project":"CORD-19-Sentences","denotations":[{"id":"TextSentencer_T989","span":{"begin":0,"end":174},"obj":"Sentence"},{"id":"T38529","span":{"begin":0,"end":174},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"attributes":[{"subj":"TextSentencer_T989","pred":"source","obj":"CORD-19-Sentences"},{"subj":"T38529","pred":"source","obj":"CORD-19-Sentences"}]},{"project":"CORD-19_Custom_license_subset","denotations":[{"id":"T34","span":{"begin":0,"end":174},"obj":"Sentence"}],"attributes":[{"subj":"T34","pred":"source","obj":"CORD-19_Custom_license_subset"}]},{"project":"CORD-19-PD-HP","denotations":[{"id":"T82","span":{"begin":86,"end":100},"obj":"Phenotype"}],"attributes":[{"id":"A82","pred":"hp_id","subj":"T82","obj":"http://purl.obolibrary.org/obo/HP_0020174"},{"subj":"T82","pred":"source","obj":"CORD-19-PD-HP"}]}],"config":{"attribute types":[{"pred":"source","value type":"selection","values":[{"id":"CORD-19-Sentences","color":"#ece793","default":true},{"id":"CORD-19_Custom_license_subset","color":"#cd93ec"},{"id":"CORD-19-PD-HP","color":"#93ecb3"}]}]}}